Quality Assurance
QUALITY ASSURANCE
The total investment for the Phase III project is 50 million yuan, with key construction components and scale including factory buildings, R&D facilities, and supporting infrastructure, totaling 21,000 m² of floor space. The project plans to establish five active pharmaceutical ingredient (API) production lines: 1. Lidocaine Hydrochloride Production Line; 2. Dehydrocholesterol Production Line; 3. Furosemide Production Line; 4. Diphenhydramine Hydrochloride Production Line; 5. Calamine Production Line. Upon completion, the project will achieve an annual production capacity of 20 tons of other anesthetic drugs, 4 tons of various vitamins and their derivatives, 2.5 tons of cardiovascular system medications, and 2.5 tons of antihistamine drugs, along with 100 tons of dermatological or topical pharmaceutical products.
Phase III Project
2025-10-24
Project Overview: Active Pharmaceutical Ingredient Production Line Project Design Capacity: 20 tons/year of Lidocaine Hydrochloride and 4 tons/year of Dehydrocholesterol Annual Output Value: 400 million
undefined
Contact Us
Company Address: No. 51, West Section of Changjiang Road, South Area, Shifang Economic Development Zone, Sichuan
Copyright ©2025 Sichuan Yuxin Pharmaceutical Co., Ltd. Power By：300.cn